Evaluating the potential of the new, higher dose version of Eylea in treating Macular Edema

Executed on:Sep 29, 2022 3:00 PM EDT

Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert

Institution: University of Colorado

Assistant Professor of Ophthalmology at University of Colorado.
Manages 250 patients a month with macular edema and ~ 150 patients a month with wet AMD.
Research interests include improving treatment for diabetic eye disease, macular degeneration, and translational research.

Interview Goal

This conversation will focus on the standard of care for macular edema and the impact of newly released data from Regeneron and their higher dose version of Eylea.

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.